The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis
Zhou, Hui, Luo, Yuling, Zhu, Sha, Wang, Xi, Zhao, Yunuo, Ou, Xuejin, Zhang, Tao, Ma, XueleiVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4817-4
Date:
December, 2018
File:
PDF, 1.25 MB
english, 2018